catechin and Acquired Immunodeficiency Syndrome

catechin has been researched along with Acquired Immunodeficiency Syndrome in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (50.00)18.2507
2000's1 (25.00)29.6817
2010's1 (25.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, W; Han, W; Jiang, F; Si, Y; Wu, Z; Yi, K; Zhao, Y1
Golks, I; Hartung, A; Müller, C; Schäfer, S1
McKeough, M; McKinley, G; Robinson, D; Safrin, S; Spruance, SL1
Holodniy, M; Khandwala, A; Koch, J; Mistal, M; Pennington, JE; Porter, SB; Schmidt, JM1

Trials

1 trial(s) available for catechin and Acquired Immunodeficiency Syndrome

ArticleYear
A double blind, randomized, placebo-controlled phase II study to assess the safety and efficacy of orally administered SP-303 for the symptomatic treatment of diarrhea in patients with AIDS.
    The American journal of gastroenterology, 1999, Volume: 94, Issue:11

    Topics: Acquired Immunodeficiency Syndrome; Administration, Oral; Adult; Anti-HIV Agents; Antidiarrheals; Antiviral Agents; Biopolymers; Catechin; Diarrhea; Double-Blind Method; Feces; Female; Follow-Up Studies; HIV Protease Inhibitors; Humans; Male; Middle Aged; Placebos; Safety

1999

Other Studies

3 other study(ies) available for catechin and Acquired Immunodeficiency Syndrome

ArticleYear
The evaluation of catechins that contain a galloyl moiety as potential HIV-1 integrase inhibitors.
    Clinical immunology (Orlando, Fla.), 2010, Volume: 137, Issue:3

    Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; Catechin; DNA, Viral; Enzyme-Linked Immunosorbent Assay; HIV Integrase; HIV Integrase Inhibitors; HIV-1; Humans; Pyrrolidinones; Raltegravir Potassium

2010
[Green tea against AIDS?].
    Pharmazie in unserer Zeit, 2007, Volume: 36, Issue:2

    Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; Catechin; CD4-Positive T-Lymphocytes; Humans; Models, Molecular; Tea

2007
Treatment of acyclovir-unresponsive cutaneous herpes simplex virus infection with topically applied SP-303.
    Antiviral research, 1994, Volume: 25, Issue:3-4

    Topics: Acquired Immunodeficiency Syndrome; Acyclovir; Administration, Topical; Adult; Aged; Biopolymers; Catechin; Drug Resistance, Microbial; Herpes Simplex; Humans; Male; Middle Aged

1994